Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Oncolys BioPharma
AddedFeb 15, 2024
UpdatedJun 28, 2026
Oncolys BioPharma

Oncolys BioPharma

Public

Tokyo-based Oncolys BioPharma Inc. develops and sells targeted drugs for cancer and serious infections.

HQ
Tokyo, Tokyo, JP
Founded
2004
Overview
Compare
Employees
Website

Founded in Tokyo, Japan, Oncolys BioPharma Inc. is dedicated to developing and commercializing innovative pharmaceutical and diagnostic products. The company's core mission is to improve patient outcomes by targeting cancer and serious infectious diseases. Oncolys BioPharma offers a range of drugs specifically designed to treat these conditions and also provides viral inspection services. Their market focus includes both the pharmaceutical and diagnostic sectors, aiming to address unmet medical needs through advanced biotechnology.

Notable figures affiliated with Oncolys BioPharma include key researchers and industry experts who drive their innovative projects. The company has attracted significant investment from venture capital firms specializing in biotech. Among its key achievements are the development of several promising drug candidates currently in clinical trials, which have the potential to revolutionize treatment protocols for cancer and infectious diseases. Overall, Oncolys BioPharma has made a substantial impact in the biotech industry, contributing to advancements in targeted therapies and diagnostic technologies.

Oncolys BioPharma - Similar Companies

Taiho Pharmaceutical Co. logo

Taiho Pharmaceutical Co.

taiho.co.jp

Oncolix logo

Oncolix

OncXerna Therapeutics logo

OncXerna Therapeutics

oncxerna.com

Oncoholdings logo

Oncoholdings

Shionogi & Co. logo

Shionogi & Co.

Oncolyze logo

Oncolyze

oncolyze.com

Clovis Oncology logo

Clovis Oncology

ONO Pharmaceutical logo

ONO Pharmaceutical

Astellas Pharma logo

Astellas Pharma

UroGen Pharma logo

UroGen Pharma

urogen.com

OnCusp Therapeutics logo

OnCusp Therapeutics

oncusptx.com

BioPro Pharmaceutical logo

BioPro Pharmaceutical

OncoTartis logo

OncoTartis

Cullinan Oncology logo

Cullinan Oncology

MacroGenics logo

MacroGenics

macrogenics.com

Oncolys BioPharma - Quick Facts

Who are Oncolys BioPharma's competitors?

Companies similar to Oncolys BioPharma include Taiho Pharmaceutical Co., Oncolix, OncXerna Therapeutics and Oncoholdings.

When was Oncolys BioPharma founded?

Oncolys BioPharma was founded in 2004.

Where is Oncolys BioPharma's headquarters located?

Oncolys BioPharma's headquarters is located in Tokyo, Tokyo, JP.

How many employees does Oncolys BioPharma have?

Oncolys BioPharma has 33 employees as of Feb 6, 2024.

Oncolys BioPharma - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Japan
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Diagnostics
  • Pharmaceuticals
Tags
  • Financial
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified